What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
The scientist’s investigation covers issues in Gerontology, Alzheimer's disease, Disease, Dementia and Internal medicine.
His Gerontology research includes elements of Psychological intervention, Physical therapy, Activities of daily living, Geriatrics and Malnutrition.
Bruno Vellas combines subjects such as Central nervous system disease, Weight loss, Psychiatry, Cognitive disorder and Cohort with his study of Alzheimer's disease.
His studies in Disease integrate themes in fields like Biomarker, Clinical trial and Alternative medicine.
His Dementia study combines topics in areas such as Cognition, MEDLINE and Quality of life.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Surgery and Endocrinology.
His most cited work include:
- ESPEN Guidelines for Nutrition Screening 2002 (1760 citations)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)
- Frailty Consensus: A Call to Action (1747 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Gerontology, Disease, Dementia, Internal medicine and Alzheimer's disease.
The various areas that he examines in his Gerontology study include Psychological intervention, Sarcopenia, Intervention, Activities of daily living and Geriatrics.
He interconnects Observational study, Clinical trial, Intensive care medicine, Physical therapy and Pediatrics in the investigation of issues within Disease.
Bruno Vellas has included themes like Psychiatry, Cognition and MEDLINE in his Dementia study.
His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo, Endocrinology and Oncology.
His research in Alzheimer's disease intersects with topics in Prospective cohort study, Central nervous system disease, Degenerative disease and Cognitive disorder.
He most often published in these fields:
- Gerontology (36.21%)
- Disease (32.61%)
- Dementia (30.01%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (25.79%)
- Disease (32.61%)
- Dementia (30.01%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Disease, Dementia, Gerontology and Cognition are his primary areas of study.
The study incorporates disciplines such as Placebo and Oncology in addition to Internal medicine.
His Disease study combines topics from a wide range of disciplines, such as Geriatrics gerontology, Neurology, Intensive care medicine and Clinical trial.
His Dementia study integrates concerns from other disciplines, such as Randomized controlled trial, Physical therapy, Activities of daily living, Neuroscience and Pediatrics.
His Physical therapy research is multidisciplinary, incorporating elements of Medical prescription and Quality of life.
In his research, Integrated care is intimately related to Geroscience, which falls under the overarching field of Gerontology.
Between 2017 and 2021, his most popular works were:
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease (385 citations)
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease (273 citations)
- Pitfalls in the measurement of muscle mass: a need for a reference standard (201 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Bruno Vellas mostly deals with Internal medicine, Disease, Dementia, Clinical trial and Gerontology.
His studies deal with areas such as Placebo and Activities of daily living as well as Internal medicine.
The Disease study combines topics in areas such as Biomarker, Neurology, Neuroscience and Intensive care medicine.
Bruno Vellas studies Cognitive decline which is a part of Dementia.
His biological study spans a wide range of topics, including Intervention, Geriatrics gerontology and Drug development.
His Gerontology research is multidisciplinary, relying on both Sarcopenia, Cohort study, Public health and Polypharmacy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
